Marizyme Inc Quick Ratio (MARZ) starting from the third quarter 2024 to third quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Marizyme Inc   (MARZ)

Marizyme Inc 's Quick Ratio

MARZ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2024, Quick Ratio deteriorated to 0 a new company low.

Within Medical Equipment & Supplies industry 212 other companies have achieved higher Quick Ratio than Marizyme Inc in third quarter 2024. While Quick Ratio total ranking has improved so far during the Q3 2024 to 4445, from total ranking in the second quarter 2024 at 4670.

Explain Quick Ratio?
How much Cash & cash equivalents MARZ´s has?
What are MARZ´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MARZ Quick Ratio (Sep 30 2024)
Q3		 (Jun 30 2024)
Q2		 (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3
Y / Y Current Liabilities Change -60.03 % -16.58 % 407.84 % 806.32 % 6228.49 %
Y / Y Cash & cash equivalent Change -81.44 % -85.03 % -89.95 % -67 % -57.29 %
Quick Ratio MRQ 0 0 0 0.01 0.01
MARZ's Total Ranking # 4445 # 4670 # 3503 # 3862 # 4318
Seq. Current Liabilities Change -22.24 % -5.43 % 80.03 % -69.81 % 62.31 %
Seq. Cash & cash equivalent Change 166.12 % -2.56 % -79.75 % -64.66 % 114.66 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 213
Healthcare Sector # 972
Overall Market # 4445


Quick Ratio Statistics
High Average Low
11.15 1.14 0
(Sep 30 2020)   (Mar 31 2020)




Financial Statements
Marizyme Inc 's Current Liabilities $ 30 Millions Visit MARZ's Balance sheet
Marizyme Inc 's Cash & cash equivalent $ 0 Millions Visit MARZ's Balance sheet
Source of MARZ's Sales Visit MARZ's Sales by Geography


Cumulative Marizyme Inc 's Quick Ratio

MARZ's Quick Ratio for the trailling 12 Months

MARZ Quick Ratio

 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 0.15 % 205.52 % 1343.2 % 2371.91 % 1925.94 %
Y / Y Cash & cash equivalent TTM Growth -79.06 % -67.44 % -76.87 % -81.58 % -84.38 %
Quick Ratio TTM 0 0 0.01 0.01 0.01
Total Ranking TTM # 3654 # 3654 # 3144 # 3406 # 5519
Seq. Current Liabilities TTM Growth -25.44 % -4.15 % 21.55 % 15.29 % 127.45 %
Seq. Cash & cash equivalent TTM Growth -54.48 % -20.95 % -25.32 % -22.09 % -29.22 %

Quick ratio ranking by company, industry and sector >> Back to MARZ Financial Strength Comparisons >> Go to Compare MARZ Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in MARZ's Current Liabilities to $29.98 millions, cumulative Quick Ratio